Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin.
Pooled human immunoglobulin suitable for intravenous administration (IGIV) was evaluated in the prophylaxis and treatment of herpes simplex virus (HSV) type 1 encephalitis in a murine model. Four-week-old BALB/c mice received a single intraperitoneal injection of IGIV or saline 24 h before or up to...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1987
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174861/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2821882/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.7.1006 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|